← Back to Screener
Becton, Dickinson and Co. (BDX)
Price$158.64
Favorite Metrics
Price vs S&P 500 (26W)1.26%
Price vs S&P 500 (4W)-6.60%
Market Capitalization$45.12B
P/E Ratio (Annual)26.89x
Indicated Dividend Yield (Annual)2.65%
All Metrics
P/CF (Annual)13.16x
Book Value / Share (Quarterly)$88.79
P/TBV (Annual)3.34x
Indicated Dividend (Annual)$4.16
Revenue Growth (3Y)4.99%
Cash Flow / Share (Quarterly)$9.24
Payout Ratio (TTM)67.90%
Price vs S&P 500 (YTD)0.09%
Gross Margin (TTM)46.42%
Net Profit Margin (TTM)8.01%
EPS (TTM)$6.12
10-Day Avg Trading Volume2.88M
EPS Excl Extra (TTM)$6.12
Revenue Growth (5Y)6.32%
EPS (Annual)$5.82
Dividend / Share (Annual)$4.16
ROI (Annual)3.76%
Gross Margin (Annual)45.89%
Net Profit Margin (5Y Avg)8.83%
Cash / Share (Quarterly)$2.64
P/E Basic Excl Extra (TTM)25.68x
Revenue Growth QoQ (YoY)1.63%
EPS Growth (5Y)13.42%
P/E Normalized (Annual)26.89x
ROA (Last FY)3.03%
Revenue Growth TTM (YoY)6.22%
EBITD / Share (TTM)$17.51
ROE (5Y Avg)6.97%
Operating Margin (TTM)12.15%
Cash Flow / Share (Annual)$9.36
P/B Ratio1.78x
P/B Ratio (Quarterly)2.19x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)2.92x
Net Interest Coverage (TTM)4.00x
ROA (TTM)3.20%
EPS Growth QoQ (YoY)28.08%
EV / EBITDA (TTM)12.71x
EPS Incl Extra (Annual)$5.82
Current Ratio (Annual)1.11x
Quick Ratio (Quarterly)0.40x
3-Month Avg Trading Volume2.49M
52-Week Price Return1.59%
EV / Free Cash Flow (Annual)23.94x
P/E Incl Extra (TTM)25.68x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$57.09
P/S Ratio (Annual)2.07x
Asset Turnover (Annual)0.39x
52-Week High$187.35
Operating Margin (5Y Avg)11.58%
EPS Excl Extra (Annual)$5.82
CapEx CAGR (5Y)-0.24%
Tangible BV CAGR (5Y)9.94%
26-Week Price Return8.15%
Quick Ratio (Annual)0.46x
13-Week Price Return-3.11%
Total Debt / Equity (Annual)0.76x
Current Ratio (Quarterly)1.05x
Enterprise Value$63,923.457
Revenue / Share Growth (5Y)5.84%
Asset Turnover (TTM)0.40x
Book Value / Share Growth (5Y)1.66%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)3.05x
Pretax Margin (Annual)8.61%
Cash / Share (Annual)$2.27
3-Month Return Std Dev24.26%
Gross Margin (5Y Avg)45.57%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)10.40%
EBITDA Interim CAGR (5Y)-8.76%
ROE (Last FY)6.61%
Net Interest Coverage (Annual)4.33x
EPS Basic Excl Extra (Annual)$5.82
P/FCF (TTM)17.15x
Receivables Turnover (TTM)8.52x
EV / Free Cash Flow (TTM)24.30x
Total Debt / Equity (Quarterly)0.77x
EPS Incl Extra (TTM)$6.12
Receivables Turnover (Annual)7.25x
ROI (TTM)3.93%
Dividend Growth Rate (5Y)3.22%
P/S Ratio (TTM)2.06x
Pretax Margin (5Y Avg)9.08%
Revenue / Share (Annual)$75.70
Tangible BV / Share (Annual)$56.01
Forward P/E12.70x
Free OCF CAGR (5Y)-0.73%
Price vs S&P 500 (52W)-33.04%
P/E Ratio (TTM)25.68x
EPS Growth TTM (YoY)1.63%
Year-to-Date Return4.02%
5-Day Price Return1.87%
EPS Normalized (Annual)$5.82
ROA (5Y Avg)3.21%
Net Profit Margin (Annual)7.68%
Month-to-Date Return0.90%
Cash Flow / Share (TTM)$13.03
EBITD / Share (Annual)$17.23
EPS Growth (3Y)-2.10%
Operating Margin (Annual)11.74%
LT Debt / Equity (Annual)0.69x
P/CF (TTM)13.30x
ROI (5Y Avg)4.08%
P/E Excl Extra (TTM)25.68x
LT Debt / Equity (Quarterly)0.67x
EPS Basic Excl Extra (TTM)$6.12
P/TBV (Quarterly)3.40x
Payout Ratio (Annual)71.28%
P/B Ratio (Annual)2.10x
Dividend / Share (TTM)$4.17
Inventory Turnover (TTM)2.96x
Pretax Margin (TTM)8.98%
Book Value / Share (Annual)$88.96
Price vs S&P 500 (13W)-5.49%
Net Margin Growth (5Y)7.14%
Dividend Yield (TTM)2.64%
Beta0.28x
P/FCF (Annual)16.90x
Revenue / Share (TTM)$76.70
ROE (TTM)6.93%
52-Week Low$127.54
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.61
3.61
3.70
3.70
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
GMEDGLOBUS MEDICAL INC | 4.37x | 30.08% | 67.41% | 20.33% | $96.82 |
About
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, including needles, syringes, and sharps-disposal units, alongside prefilled devices, diagnostic instruments, reagents, and flow cytometry and cell-imaging systems. Following its 2025 spinoff, the company operates across four segments: Medical Essentials (34% of revenue), Interventional (28%), Connected Care (25%), and Biopharma (13%). International markets represent 43% of total sales.